Sobre el grupo


Investigador Principal

Luis Palomera Bernal 

Equipo

Alberto Argón Arcarazo, Beatriz Martínez Lázaro, Clara Garcia Castell, Esther Franco García, Fernando Joaquin Sevil Puras, Gemma Azaceta Reinares, Guillermo Haces Tirado, Javier Castells Sierra, José Antonio Moreno Chulilla, Luis Antonio Mayor Pérez, Luis Ignacio Sancho Val, Mª del Mar Moles Guerrero, Mª Isabel Miravete Duque, Mª Teresa Olave Rubio, Manuela Dobon Rebollo, Miguel Paricio Moreno, Olga Gavín Sebastián, Pedro José Paul Vidaller, Rosana Díez Angulo, Victoria Minerva Murillo Cortés

Hospital Clínico Universitario Lozano Blesa

Líneas de Investigación


Estudios translaccionales de inmunoterapia aplicada a patología linfoide

Investigación en enfermedades oncohematológicas

Investigación en patología trombótica

Investigación en patología hematológica no oncológica

Publicaciones más relevantes


Hernandez-Boluda J, Pereira A, Pastor-Galan I, Alvarez-Larran A, Savchuk A, Puerta J, Sanchez-Pina J, Collado R, Diaz-Gonzalez A, Angona A, Sagues M, Garcia-Gutierrez V, Boque C, Osorio S, Vallansot R, Palomera L, Mendizabal A, Casado L, Perez-Encinas M, Perez-Lopez R, Ferrer-Marin F, Sanchez-Guijo F, Garcia C, de las Heras N, Lopez-Lorenzo J, Cervantes F, Steegmann J, GELMC. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients. Blood Cancer J. 2018. 8: 91. 10.1038/s41408-018-0125-0.

Jimenez-Ubieto A, Grande C, Caballero D, Yanez L, Novelli S, Hernandez-Garcia M, Manzanares M, Arranz R, Ferreiro J, Bobillo S, Mercadal S, Galeo A, Jimenez J, Moraleda J, Vallejo C, Albo C, Perez E, Marrero C, Magnano L, Palomera L, Jarque I, Martinez-Sanchez P, Martin A, Coria E, Lopez-Guillermo A, Salar A, Lahuerta J, GELTAMO Grp Espanol Linfomas Tr. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment. Hematol Oncol. 2018. 36(5): 765 - 772. 10.1002/hon.2553.

Sanoja-Flores L, Flores-Montero J, Garces J, Paiva B, Puig N, Garcia-Mateo A, Garcia-Sanchez O, Corral-Mateos A, Burgos L, Blanco E, Hernandez-Martin J, Pontes R, Diez-Campelo M, Millacoy P, Rodriguez-Otero P, Prosper F, Merino J, Vidriales M, Garcia-Sanz R, Romero A, Palomera L, Rios-Tamayo R, Perez-Andres M, Blanco J, Gonzalez M, van Dongen J, Durie B, Mateos M, San-Miguel J, Orfao A, EuroFlow Consortium. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC). Blood Cancer J. 2018. 8: 117. 10.1038/s41408-018-0153-9.

Rodriguez-Otero P, Mateos M, Martinez-Lopez J, Martin-Calvo N, Hernandez M, Ocio E, Rosinol L, Martinez R, Teruel A, Gutierrez N, Bargay J, Bengoechea E, Gonzalez Y, de Oteyza J, Gironella M, Encinas C, Martin J, Cabrera C, Palomera L, de Arriba F, Cedena M, Paiva B, Puig N, Oriol A, Blade J, Lahuerta J, San Miguel J. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia. 2018. 32(11): 2427 - 2434. 10.1038/s41375-018-0072-6.

Casado L, Garcia-Ormena N, Mba C, Garcia-Gutierrez J, Giraldo P, Perez-Encinas M, De Paz R, Ayala R, Bautista G, Osorio S, Requena M, Palomera L, Penarrubia M, Calle C, Hernandez-Rivas J, Steegmann J. ANALYSIS OF DEEP MOLECULAR RESPONSES ACHIEVED BY THE MULTIPLE SEQUENCES OF TREATMENTS WITH ITKS IN LMC. LONG FOLLOW-UP STUDY OF THE LMC SPANISH REGISTRY. Haematologica. 2018. 103: 231 - 231. .

Lopez-Anglada L, Cueto-Felgueroso C, Rosinol L, Oriol A, Teruel A, de la Guia A, Bengoechea E, Palomera L, de Arriba F, Hernandez J, Granell M, Penalver F, Garcia-Sanz R, Besalduch J, Gonzalez Y, Martinez R, Hernandez M, Gutierrez N, Puerta P, Valeri A, Paiva B, Blade J, Mateos M, San Miguel J, Lahuerta J, Martinez-Lopez J, GEM Grp Espanol MM, PETHEMA Programa El Estudio. Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials. PLoS One. 2018. 13(9): e0203392. 10.1371/journal.pone.0203392.

Jimenez-Ubieto A, Grande C, Caballero D, Yanez L, Hernandez-Garcia M, Novelli S, Arranz R, Ferreiro J, Bobillo S, Mercadal S, Galeo A, Jimenez J, Moraleda J, Vallejo C, Albo C, Perez E, Marrero C, Magnano L, Palomera L, Jarque I, Martinez-Sanchez P, Martin A, Coria E, Lopez-Guillermo A, Salar A, Lahuerta J, Cooperative Study Grp. Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry. Bone Marrow Transplant.. 2018. 53(6): 780 - 783. 10.1038/s41409-018-0096-6.

Sebastian O, Fernandez M, Fernandez R, Bernal L. Anticoagulation with rivaroxaban in a hematology unit: clinical profile, events and discontinuation rates in real-life patients with nonvalvular atrial fibrillation. Futur. Cardiol.. 2018. 14(3): 25 - 30. 10.2217/fca-2018-0023.

Otra Actividad